A. ÇETİNKAYA Et Al. , "Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study," 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021) , Japan, 2021
ÇETİNKAYA, A. Et Al. 2021. Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study. 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021) , (Japan).
ÇETİNKAYA, A., ÇAĞLAYAN, M. G., ÜNAL, M. A., BEYAZKILIÇ, P., ELBÜKEN, Ç., BELLUR ATİCİ, E., ... ÖZKAN, S. A.(2021). Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study . 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021), Japan
ÇETİNKAYA, AHMET Et Al. "Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study," 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021), Japan, 2021
ÇETİNKAYA, AHMET Et Al. "Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study." 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021) , Japan, 2021
ÇETİNKAYA, A. Et Al. (2021) . "Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study." 31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021) , Japan.
@conferencepaper{conferencepaper, author={AHMET ÇETİNKAYA Et Al. }, title={Binding of palbociclib to human serum albumin: Fluorescence quenching and molecular docking study}, congress name={31st International Symposium on Pharmaceutical and Biomedical Analysis (PBA2021)}, city={}, country={Japan}, year={2021}}